Cultured human airway smooth muscle cells stimulated by interleukin-1β enhance eosinophil survival

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 6, 1998, Pages 910-919

  Hallsworth, Matthew P ^a   Soh, Cecilia P C ^a   Twort, Charles H C ^a   Lee, Tak H ^a   Hirst, Stuart J ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL1RN PROTEIN, HUMAN; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CELL SURVIVAL; CULTURE MEDIUM; DRUG ANTAGONISM; EOSINOPHIL; FEMALE; HUMAN; KINETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SMOOTH MUSCLE;

ADULT; AGED; ANTIBODIES; BRONCHI; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DEXAMETHASONE; EOSINOPHILS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INDOMETHACIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KINETICS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 0032239356     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.6.3275     Document Type: Article

References (54)

1. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Sinomy-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
2. Poston, R., P. Chanez, J. Y. Lacoste, P. Litchfield, T. H. Lee, and J. Bousquet. 1992. Immunohistochemical characterisation of the cellular infiltration of asthmatic bronchi. Am. Rev. Respir. Dis. 145;918-921.
3. Azzawi, M., B. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, G. Knowles, B. Assuofi, J. V. Collins, S. R. Durham, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies instable atopic asthmatics. Am. Rev. Respir. Dis. 142:1407-1413.
4. Bousquet, J., A. M. Vignola, P. Chanez, A. M. Campbell, G. Bonsignore, and F.-B. Michel. 1995. Airways remodelling in asthma: no doubt, no more? Int. Arch. Allergy Immunol. 107:211-214.
5. James, A. L., P. D. Pare, and J. C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:242-246.
6. Jeffrey, P. K. 1992. Pathology of asthma. Br. Med. Bull. 48:23-39.
7. Halayko, A., and N. L. Stephens. 1994. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma. Can. J. Physiol. Pharmacol. 72:1448-1457.
8. Hirst, S. J. 1996. Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. Eur. Respir. J. 9:808-820.
9. Johnson, S. R., and A. J. Knox. 1997. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18:288-292.
10. Belvisi, M. G., M. A. Saunders, E.-B. Haddad, S. J. Hirst, M. H. Yacoub, P. J. Barnes, and J. A. Mitchell. 1997. Induction of cyclo-oxygenase-2 by cytokines in human airway smooth muscle cells: novel inflammatory role of this cell type. Br. J. Pharmacol. 120:910-916.
11. Pang, L., and A. J. Knox. 1997. Effect of interleukin-1β, tumor necrosis factor-α and interferon-γ on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121:579-587.
12. John, M., S. J. Hirst, P. J. Jose, A. Robichaud, N. Berkman, C. Witt, C. H. C. Twort, P. J. Barnes, and K. F. Chung. 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines. J. Immunol. 158:1841-1847.
13. Watson, M. L., S. P. Grix, N. J. Jordan, G. A. Place, S. Dodd, J. Leithead, C. T. Poll, and J. Westwick. 1996. IL-8 production by human cultured airway smooth muscle. Br. J. Pharmacol. 119:48P. (Abstr.)
14. John, M., B.-T. Au, P. J. Jose, S. Lim, M. Saunders, P. J. Barnes, J. A. Mitchell, M. G. Belvisi, and K. F. Chung. 1998. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:84-90.
15. Ghaffar, O., E. Minshall, B. Lamkhioued, S. Shore, P. Renzi, M. Rothenburg, A. Luster, and Q. Hamid. 1997. Eotaxin mRNA expression in mouse and human airway smooth muscle. Am. J. Resir. Crit. Care Med. 155: A372. (Abstr.)
16. Herrick, D. J., H. Hakonarson, and M. M. Grunstein. 1996. Induced expression of IL-6 and IL-8 cytokines in human bronchial smooth muscle cells exposed to asthmatic serum or cytokines. Am. J. Respir. Crit. Care Med. 153:A164. (Abstr.)
17. Furie, M. B., and G. J. Randolph. 1995. Chemokines and tissue injury. Am. J. Pathol. 146:1287-1301.
18. Warringa, R. A. J., H. J. J. Mengelers, J. A. M. Raaijmakers, P. L. B. Bruijnzeel, and L. Koenderman. 1993. Upregulation of formyl-peptide- and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J. Allergy Clin. Immunol. 91:1198-1205.
19. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassan, H. Smith, X. Shi, J. Gonzalo, W. Newman, J. Gutierrez-Ramos, and C. R. Mackay. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
20. Woolley, K. L., P. G. Gibson, K. Carty, A. J. Wilson, S. H. Twaddell, and M. J. Woolley. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154:237-243.
21. Sousa, A. R., S. J. Lane, J. A. Nakhosteen, T. H. Lee, and R. N. Poston. 1996. Expression of interleukin-1 beta and interleukin-1 receptor antagonist on asthmatic bronchial epithelium. Am. J. Respir. Crit. Care Med. 154: 1061-1066.
22. Pujol, J. L., B. Cosso, J. P. Daures, J. Clot, F. B. Michel, and P. Goddard. 1990. Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int. Arch. Allergy Appl. Immunol. 91:207-210.
23. Mattoli, S., V. L. Mattoso, M. Solopertro, L. Allegra, and A. Fasoli. 1991. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic non-allergic asthma. J. Allergy Clin. Immunol. 87:794-802.
24. Broidie, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
25. Hirst, S. J., P. J. Barnes, and C. H. C. Twort. 1996. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am. J. Physiol. 270:L415-L428.
26. 2-adrenoceptor stimulation. Br. J. Pharmacol. 121:361-368.
27. Hirst, S. J., P. J. Barnes, and C. H. C. Twort. 1992. Quantifying proliferation of cultured human and rabbit airway smooth muscle in response to serum and platelet-derived growth factor. Am. J Respir. Cell Mol. Biol. 7:574-581.
28. Hirst, S. J., and C. H. C. Twort. 1997. Effects of extracellular matrix on human airway smooth muscle cell proliferation and phenotype. Am. J. Respir. Crit Care Med. 155:A371. (Abstr.)
29. Warley, A., K. P. B. Cracknell, H. B. Cammish, C. H. C. Twort, J. P. T. Ward, and S. J. Hirst. 1994. Preparation of cultured airway smooth muscle cells for study of intracellular element concentrations by X-ray microanalysis: comparison of whole cell mounts with cryosections. J. Microsc. 175: 143-153.
30. Campbell, J. H., and G. R. Campbell. 1993. Culture techniques and their applications to studies of vascular smooth muscle. Clin. Sci. 85:501-513.
31. Denziot, F., and R. Lang. 1986. Rapid colorimetric assay for growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol. Methods 89:271-277.
32. Hansel, T. T., I. J. M. DeVries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105-110.
33. Borish, L., J. J. Mascali, J. Dishuck, W. R. Beam, R. J. Martin, and L. J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1β in asthma. J Immunol. 149:3078-3082.
34. Dinarello, C. A., and S. M. Wolff. 1992. The role of interleukin-1β in disease. N. Engl. J. Med. 328:106-113.
35. Spry, C. J. F. 1993. The natural history of the eosinophil. In Immunopharmacology of Eosinophils. H. Smith and R. M. Cook, editors. Academic Press, London. 1-9.
36. Rothenburg, M. E., W. F. Owen, D. S. Silberstein, J. Woods, R. J. Soberman, K. F. Austen, and R. L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3. J. Clin. Sci. 81:1986-1992.
37. Rothenburg, M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen. 1989. Interleukin-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311-2316.
38. Her, E., J. Frazer, F. K. Austen, and W. F. Owen. 1991. Eosinophil haematopoetins antagonise the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Sci. 88:1982-1987.
39. 4 generation by human eosinophils stimulated with ionophore (A23187) as granulocyte-macrophage colony stimulating factor. Am. Rev. Respir. Dis. 140:1340-1347.
40. Burke, L., M. P. Hallsworth, T. M. Litchfield, R. Davidson, and T. H. Lee. 1991. Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte-macrophage colony stimulating factor. J. Allergy Clin. Immunol. 88:226-235.
41. Sousa, A. R., R. N. Poston, S. J. Lane, J. A. Nakhosteen, and T. H. Lee. 1993. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147:1557-1561.
42. Marini, M., E. Avoni, J. Hollemborg, and S. Mattoli. 1992. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from non-atopic patients with symptomatic asthma. Chest 102:661-669.
43. Robinson, D. S., S. Ying, A. M. Bentley, O. Meng, J. North, S. R. Durham, A. B. Kay, and Q. A. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing ribonucleic acid for cytokines, asthma symptoms and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397-403.
44. Zhang, S., Q. Mohammed, A. Burbidge, C. M. Morland, and W. R. Roche. 1996. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro. Eur. Respir. J. 9:1839-1846.
45. Vancheri, C., J. Gauldie, J. Bienenstock, G. Cox, R. Scicchitano, A. Staniscz, and M. Jordana. 1989. Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor mediates eosinophil survival in vitro. Am. J. Respir. Cell Mol. Biol. 1:289-295.
46. Kuhn, C., and J. A. McDonald. 1991. The roles of the myofibroblast in idiopathic fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138:1257-1265.
47. Ohta, K., R. L. Mortenson, R. A. F. Clark, N. Hirose, and T. E. King. 1995. Immunohistochemical identification and characterisation of smooth muscle-like cells in idiopathic fibrosis. Am. J. Respir. Crit. Care Med. 152:1659-1665.
48. Gizycki, M. J., E. Adelroth, A. V. Rogers, P. M. O'Byrne, and P. K. Jeffery. 1997. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol. 16:664-673.
49. Arend, W. P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54: 167-227.
50. Saunders, M. A., J. A. Mitchell, P. M. Seldon, M. H. Yacoub, P. J. Barnes, M. A. Giembycz, and M. G. Belvisi. 1997. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120:545-546.
51. Hamid, Q., Y. Song, T. C. Kotsimbos, E. Minshall, T. R. Bai, R. Hegele, and J. C. Hogg. 1997. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 100:44-51.
52. Filonzi, E. L., H. Zoellner, H. Stanton, and J. A. Hamilton. 1993. Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle. Atherosclerosis 99:241-252.
53. Haslett, C. 1992. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin. Sci. 83:639-648.
54. Hallsworth, M. P., M. A. Giembycz, P. J. Barnes, and T. H. Lee. 1996. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br. J. Pharmacol. 117:79-86.